A Study to Compare Early and Partial Weight-bearing After Hallux Valgus Surgery
Launched by ENTE OSPEDALIERO CANTONALE, BELLINZONA · Sep 6, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different approaches to weight-bearing after foot surgery can impact recovery. Specifically, it compares two methods for patients who have undergone a modified Lapidus arthrodesis surgery, which is a procedure to correct a bunion (hallux valgus). The trial will assess whether patients do better with immediate full weight-bearing on their foot or with limited weight-bearing (10-15 kg) for the first six weeks after surgery.
To participate, you need to be between the ages of 65 and 74 and have had the specific foot surgery, possibly including additional procedures on neighboring toes. You also need to be willing and able to follow the study's requirements and sign a consent form. Participants can expect regular follow-ups to monitor their recovery and will be contributing valuable information to help improve post-surgery care for future patients. Please note that individuals with certain medical conditions or previous foot surgeries may not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patient who undergo modified Lapidus arthrodesis operation and associated with:
- • Additional surgical gestures such as e.g. interventions on the proximal phalanx of the first finger (Akin) or interventions on the 2nd and / or 3rd ray (Weil / Hohmann) \[23,24\].
- • Willingness and ability to participate in the trial
- • Signed Informed Consent
- Exclusion Criteria:
- • Diabetes mellitus
- • Rheumatoid arthritis
- • Previous foot surgery
- • Classic Lapidus surgery
- • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, general physical problem of the participant, etc.
- • Inability or contraindications to undergo the investigated intervention
- • Pregnant women
About Ente Ospedaliero Cantonale, Bellinzona
Ente Ospedaliero Cantonale (EOC) in Bellinzona is a prominent healthcare institution dedicated to providing high-quality medical services and advancing clinical research. As a key sponsor of clinical trials, EOC focuses on fostering innovative healthcare solutions and improving patient outcomes through rigorous scientific inquiry. With a commitment to ethical standards and collaboration, EOC plays an essential role in the development of new therapies and medical practices, leveraging its expertise and resources to contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lugano, , Switzerland
Patients applied
Trial Officials
Martin Riegger, MD
Principal Investigator
EOC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials